+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections



Characterization of Two Metal Binding Lipoproteins as Vaccine Candidates for Enterococcal Infections



Plos one 10(8): E0136625



Enterococcus faecium and faecalis are Gram-positive opportunistic pathogens that have become leading causes of nosocomial infections over the last decades. Especially multidrug resistant enterococci have become a challenging clinical problem worldwide. Therefore, new treatment options are needed and the identification of alternative targets for vaccine development has emerged as a feasible alternative to fight the infections caused by these pathogens. We extrapolate the transcriptomic data from a mice peritonitis infection model in E. faecalis to identify putative up-regulated surface proteins under infection conditions in E. faecium. After the bionformatic analyses two metal binding lipoproteins were identified to have a high homology (>72%) between the two species, the manganese ABC transporter substrate-binding lipoprotein (PsaAfm,) and the zinc ABC transporter substrate-binding lipoprotein (AdcAfm). These candidate lipoproteins were overexpressed in Escherichia coli and purified. The recombinant proteins were used to produce rabbit polyclonal antibodies that were able to induce specific opsonic antibodies that mediated killing of the homologous strain E. faecium E155 as well as clinical strains E. faecium E1162, Enterococcus faecalis 12030, type 2 and type 5. Mice were passively immunized with the antibodies raised against recombinant lipoproteins, showing significant reduction of colony counts in mice livers after the bacterial challenge and demonstrating the efficacy of these metal binding lipoproteins as promising vaccine candidates to treat infections caused by these enterococcal pathogens. Overall, our results demonstrate that these two metal binding lipoproteins elicited specific, opsonic and protective antibodies, with an extensive cross-reactivity and serotype-independent coverage among these two important nocosomial pathogens. Pointing these two protein antigens as promising immunogens, that can be used as single components or as carrier proteins together with polysaccharide antigens in vaccine development against enterococcal infections.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057387553

Download citation: RISBibTeXText

PMID: 26322633


Related references

Identification of peptidoglycan-associated proteins as vaccine candidates for enterococcal infections. Plos one 9(11): E111880, 2014

Recombinant bacterial lipoproteins as vaccine candidates. Expert Review of Vaccines 14(12): 1623-1632, 2015

Mycobacterial lipoproteins as vaccine candidates for DNA and subunit vaccines against tuberculosis. Research in Immunology 149(1): 94, 1998

Recombinant hybrids of haemophilus influenzae outer membrane lipoproteins as vaccine candidates. Abstracts of the General Meeting of the American Society for Microbiology 92: 155, 1992

Cloning and expression of predicted outer membrane lipoproteins as vaccine candidates for Leptospirosis. 2007

Extracellular putative lipoproteins made by Group A Streptococcus Identification of new potential vaccine candidates. Abstracts of the General Meeting of the American Society for Microbiology 103: D-224, 2003

Enterococcal infections with special reference to phenotypic characterization & drug resistance. Indian Journal of Medical Research 119 Suppl: 22-25, 2004

Enterococcal infections with special reference to phenotypic characterization & drug resistance. Indian Journal of Medical Research 119(Suppl S): 22-25, 2004

Recombinant lipoprotein-based vaccine candidates against C. difficile infections. Journal of Biomedical Science 22: 65, 2015

Identification and assessment of new vaccine candidates for group A streptococcal infections. Vaccine 22(21-22): 2783-2790, 2004

Combat pneumococcal infections: adhesins as candidates for protein-based vaccine development. Current Drug Targets 13(3): 323-337, 2012

Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections. World Journal of Microbiology and Biotechnology 32(9): 155, 2016

Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections. Cell Chemical Biology 23(8): 1014-1022, 2016

Binding of chlorohydrocarbons to metal centers: quantitative evaluation of relative binding constants and structural characterization of the first isolable transition metal-chloromethane adduct. Journal of the American Chemical Society 123(46): 11508-9, 2001

Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine. Vaccine 30(52): 7461-7468, 2012